Skip to main content
. 2017 Mar 15;2017(3):CD012599. doi: 10.1002/14651858.CD012599

Wright 2010 FASTER trial.

Clinical features and settings Routine screening
Participants 468 participants: 78 cases and 390 controls matched for gestational and maternal age, ethnicity and storage duration
The First and Second Trimester Evaluation of Risk (FaSTER) dataset
USA ‐ 15 screening centres
October 1999 ‐ December 2002
Pregnant women
Singleton pregnancies
11‐13 and 15‐18 weeks' gestation
Study design Case‐control study
Target condition and reference standard(s) Down's syndrome: 78 cases
Reference standards: karyotyping or follow‐up to birth
Index and comparator tests Maternal age
First trimester NT (details not reported)
Fresh samples tested for:
First trimester PAPP‐A (details not reported)
Second trimester AFP, uE3, hCG and inhibin A (details not reported)
Frozen serum samples tested for:
First trimester hCG and uE3 (details not reported)
Second trimester PAPP‐A (details not reported)
 
Frozen samples tested blind to other results and pregnancy outcome
Follow‐up Details not reported
Aim of study To provide estimates and confidence intervals for the performance (detection and false positive rates) of screening for Down's syndrome using repeated measures of biochemical markers from first and second trimester maternal serum samples taken from the same woman
Test characteristics  
Reference standard used  
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Yes All women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given